|
HS Code |
794479 |
| Productname | 4-(4-Bromobenzoyl)Piperidine Hydrochloride |
| Casnumber | 112811-72-4 |
| Molecularformula | C12H14BrNO · HCl |
| Molecularweight | 304.61 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Meltingpoint | 148-152°C |
| Solubility | Soluble in water and DMSO |
| Storagecondition | Store at 2-8°C, dry place |
| Synonyms | 4-(4-Bromobenzoyl)piperidine hydrochloride; 1-(4-Bromobenzoyl)piperidine hydrochloride |
| Smiles | C1CCN(CC1)C(=O)C2=CC=C(C=C2)Br.Cl |
| Inchikey | QIYLXPZTUARODU-UHFFFAOYSA-N |
As an accredited 4-(4-Bromobenzoyl)Piperidine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-(4-Bromobenzoyl)Piperidine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In a world where new molecules are always on the horizon, 4-(4-Bromobenzoyl)Piperidine Hydrochloride shows up on the radar for good reason. Inside many labs, both academic and industrial, this compound has earned some attention for its unique chemical structure and the opportunities it offers for synthesis pathways. Compared to basic building blocks or more familiar reagents, this compound packs both a piperidine ring and a bromobenzoyl moiety together. Speaking from my own experience working alongside researchers in synthetic chemistry, this matters because tweaking a molecule’s structure at even one position opens up new avenues for downstream chemistry. Having a ready supply of a hydrochloride salt version also simplifies the weighing and dissolving parts of lab work, sidestepping nuisance static or unpredictable stickiness you see with free bases or hydroscopic powders.
Let’s look at what makes this molecule tick. The piperidine ring often appears in pharmaceutical research, especially in the development of CNS active substances. Its ability to participate in hydrogen bonding and serve as a stable scaffold makes it attractive in design work. The 4-bromobenzoyl group gives the molecule some special properties, too. Bromine atoms, bulky and polarizable, change reactivity—sometimes making handles for subsequent reactions like Suzuki or Heck couplings. In one of my projects, swapping different acylating agents let our team hit a stubborn target that nothing else could access. Compared to run-of-the-mill benzoyl piperidines, the addition of that bromine turns the tables, especially for anyone interested in late-stage functionalization.
In practical laboratory terms, the hydrochloride salt form gives this compound a strong reputation for stability and ease of manipulation. As an experienced chemist, I can say the old problem of powders floating out of the scoop disappears, and this salt sits nicely, allowing for accurate dosing and less loss during transfer. Solubility in common polar solvents stands out, too, which minimizes time spent coaxing a substance into solution. This helps in both small-scale synthesis and in routine screening work, such as designing a library for high-throughput screening. Crystallinity and purity levels reach the high marks needed for reliable analytical data—compatibility with both NMR and HPLC techniques only adds to its practical appeal.
Taking a closer look at purity, reputable suppliers often benchmark this at greater than 98%. For many research purposes, especially those setting up sensitive bioassays or advanced spectroscopy, you demand that kind of material. My own protocol demands a check with thin layer chromatography and a melting point measurement, and 4-(4-Bromobenzoyl)Piperidine Hydrochloride usually comes through on both fronts. When an impurity sneaks through, it tends to be a remnant from the starting material, easy to recognize and filter out if you’ve seen it before. This means fewer surprises later in the workflow, saving money and time.
In the push for new drug candidates, chemists recognize how minor molecular changes drive major functional differences. The combination of a piperidine structure with a bromine-substituted benzoyl marks 4-(4-Bromobenzoyl)Piperidine Hydrochloride as a flexible intermediate. I’ve seen teams use it as a starting point for bigger, more complicated molecules—sometimes by direct substitution, sometimes by backbone expansion. The bromine atom’s position allows for coupling reactions central to medicinal chemistry, such as palladium-catalyzed reactions that install new groups cleanly and directly onto the aromatic system. Among research cannabinoids, opioid receptor ligands, or even neuroprotective molecule classes, derivatives of the original molecule branch into entirely new families after a single transformation.
This product also sees use as a reference substance in analytical research. By offering a stable and well-characterized standard, 4-(4-Bromobenzoyl)Piperidine Hydrochloride lets teams tune their analytical methods—think LC-MS or NMR—without the risk of drift or contamination. This accuracy supports laboratory accreditation under quality management systems and gives other labs confidence to reproduce results. Personally, I have relied on such reference compounds to verify instrument calibration, to help design internal controls for critical experiments, and to troubleshoot finicky assay conditions.
It can sound like a luxury to have various similar molecules on hand, but chemical context matters. 4-(4-Bromobenzoyl)Piperidine Hydrochloride differs from plain piperidine hydrochloride in basic reactivity. Instead of focusing on simple alkylation or acylation chemistry, this compound invites more advanced transformations, such as cross-couplings that build up complexity without extensive protecting group manipulation. Putting the bromine at the para position—away from the acyl carbon—shifts things even more, opening up selectivity and minimizing steric hindrance if you are targeting other locations on the ring.
Comparing with other piperidine derivatives, not all salts show similar behavior in solution. Solubility and crystallinity differ based on substituent placement and type. This hydrochloride salt works well in both aqueous and certain organic systems, giving flexibility rarely matched by the parent free base or even by other halogenated versions. I’ve seen situations where the choice between a hydrochloride and a hydrobromide salt made or broke an entire run of syntheses, with downstream effects on compound isolation and purity.
Chemists owe each other and society a duty of care, so product specifications and traceability carry real weight. Reputable vendors support traceability for 4-(4-Bromobenzoyl)Piperidine Hydrochloride by documenting batch numbers, synthetic route, and test reports. Analytical profiles, such as NMR spectra or HPLC chromatograms, travel with the product so the buyer can double-check material identity any time. Forgetting these steps leads to headaches—misidentified reagents can spoil a month’s work and send you back to the drawing board, as any professional would attest. Building trust in material supply chains promotes good science and avoids repeating historical errors related to low-quality reagent purchase.
Processing and storage deserve a few words, too. As a research substance, the hydrochloride salt brings a more manageable shelf-life and less tendency to degrade under neutral or slightly acidic conditions. That means less waste and repeat ordering, helping young researchers stay within shrinking grant budgets. I’ve always encouraged my lab teams to check hygroscopicity and recommend keeping desiccated storage—common sense, but easily overlooked with seemingly robust salts. Rarely do users of this compound encounter shelf degradation, which I chalk up to the thoughtful design of making and distributing stable hydrochloride versions.
Every major innovation in pharmaceuticals starts with solid groundwork in synthetic chemistry. 4-(4-Bromobenzoyl)Piperidine Hydrochloride fits naturally into the workflows of teams chasing new lead candidates for neurological, psychiatric, or analgesic disorders. Medicinal chemists value how the compound supports scaffold hopping—the practice of swapping out ring systems or substituents to see improvements in bioactivity or selectivity. Having a readily modifiable aryl bromide lets researchers tune properties like lipophilicity, hydrogen bonding, or metabolic stability without investing years into custom synthesis.
The molecule’s use isn’t just academic. Contract research organizations and established pharmaceutical firms turn to this intermediate to scale up promising compounds for further analysis or testing. The availability of well-documented, stable, and reproducible reagent makes regulatory compliance easier. No researcher can cut corners here, as regulatory agencies require transparency on raw material quality at every development stage. By supporting reproducible science, access to reliable 4-(4-Bromobenzoyl)Piperidine Hydrochloride enables both speed and accountability.
Practical experience with halogenated benzoyl piperidines suggests they generally offer good yields in both small and moderate scales, dependent on clean reaction set-up and proper solvent choices. I recall efforts to convert similar intermediates using greener conditions, such as aqueous phase Suzuki couplings, with encouraging results. The bromide here lets teams cut out obscure reagents or avoid unnecessarily high temperatures—which, as anyone who’s mopped up after a failed run knows, spares time and resources. Fewer re-runs translate to less solvent waste and lower total consumption of starting materials—critical as labs everywhere face increased scrutiny over their waste streams and carbon footprints.
Cleanliness and ease of purification after transformations involving 4-(4-Bromobenzoyl)Piperidine Hydrochloride stand out to hands-on bench workers. Its salt form lets users easily extract product in acidic or basic washes, depending on desired outcome, and sharp melting points help separate product from unreacted starting material or side products. These little savings stack up, allowing scientists to focus on innovation, not chasing down elusive traces of product in a sea of by-products and impurities.
Today’s scientific landscape asks more from both products and people. Each time a lab worker commits a protocol to print, the expectation forces transparency from every angle—batch documentation, routes, certificates of analysis, the works. Users of 4-(4-Bromobenzoyl)Piperidine Hydrochloride find that suppliers increasingly highlight detailed specifications, including analytical verifications and purity benchmarks, to back up each shipment. While some may shrug at these details, anyone who’s lost weeks to a reagent batch gone wrong knows the value. Relying on defensible data and proven sources supports both faster learning and publication, which trickles through the whole research community. To my mind, this embodies not just rigorous science, but mutual respect—someone somewhere will reproduce this experiment, and your choice of intermediate either helps or hinders their work.
Recent efforts to bring new chemical entities from proof-of-concept to clinical trials mirror these principles. Project teams using 4-(4-Bromobenzoyl)Piperidine Hydrochloride count on uninterrupted supply, clear documentation, and the knowledge they’re not risking their entire experimental plan on a shaky batch of starting material. Being able to request impurity profiles and batch data eliminates the kinds of mishaps that knock projects off schedule and cause regulatory headaches after the fact. From lab notebook to IND submission, small decisions about these intermediates shape the broader conversation about data quality and scientific rigor.
The best synthetic chemists I know treat intermediates like 4-(4-Bromobenzoyl)Piperidine Hydrochloride as opportunities rather than obstacles. Their willingness to experiment with coupling reactions, ring rearrangements, or heterocycle integration lets them reach targets others rarely see—especially in cases where traditional routes have limited convergence. Modifying the benzoyl group, or using the bromine as a springboard for further installation, creates libraries of analogs for screening. Real breakthroughs come from that experimental attitude, not from playing it safe with standard toolkit molecules.
From a practical angle, having a reliable supply chain for these more complex intermediates supports both urgency and freedom in experimental planning. Multi-step syntheses rarely survive contact with the real world unless each intermediate comes with backups and documentation. Unlike basic amines or acids, which come and go without fanfare, the more sophisticated intermediates get tracked in inventories and tested routinely, because mistakes are costly. A dependable source of 4-(4-Bromobenzoyl)Piperidine Hydrochloride keeps projects moving and opens plenty of creative doors, both for frontline researchers and team leaders juggling bigger long-term strategies.
Many current issues facing researchers stem not from chemistry but from process gaps—missing paperwork, unclear labeling, or poor record-keeping. A straightforward approach to these is comprehensive batch documentation from supplier to bench. If every batch of 4-(4-Bromobenzoyl)Piperidine Hydrochloride moves with complete analytical data, both user and supplier protect themselves from mishaps. Sharing these data in public or consortia settings multiplies the benefit: anyone testing a new protocol can confirm their results match not just one shipment, but the entire community’s shared experience.
Safe and efficient storage links directly to ongoing usability. Desiccators, dedicated dry boxes, and routine monitoring of humidity in storage environments matter here. It’s a lesson many in chemistry learn the hard way—the best reagent in the world won’t save a protocol if the last bit of it absorbs water or oxygen and runs off-spec. Respecting product shelf-life and maintaining detailed inventory avoids unnecessary re-synthesis and delays.
Direct, transparent communication between suppliers and users also streamlines troubleshooting. Crowdsourced feedback on synthetic challenges or purification tweaks makes a difference. For example, pooled wisdom recently saved an entire graduate cohort a round of NMR headaches by narrowing a solubility problem to batch-level variations in water content, not user error. These small, community-driven wins come from sharing details, both on the supplier and the user side, building up a more resilient science culture.
High-quality intermediates like 4-(4-Bromobenzoyl)Piperidine Hydrochloride anchor the pursuit of new medicines, materials, and chemical insights. Achieving the right balance between vendor reliability, documented purity, and flexibility in handling sets up future discoveries. Speaking from personal experience, the choice to trust a well-documented, stable compound over a cheaper, off-brand analog often pays off — with cleaner data, fewer failures, and, in the big picture, healthier progress toward solutions that matter. That lesson grows more important in a landscape filled with regulatory auditing, publication standards, and the pressure to avoid irreproducible results.
Better chemistry starts on the ground, with honest reporting, careful handling, and a willingness to learn from mistakes. For research groups, the wisdom lies not just in choosing the right molecule, but in backing every step with transparency, patience, and data. Products like 4-(4-Bromobenzoyl)Piperidine Hydrochloride, with their clear track record of reliability and versatility, help the community push the boundaries of what’s possible. And as teams continue to invest in both fundamental and applied science, these choices will echo in better medicines, smarter design, and richer scientific conversations across the globe.